Clinical trials
Terminated Diabetes Mellitus, Type 2 trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 5 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 9 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Becton, Dickinson and Company | 3 |
| University of British Columbia | 3 |
| Hackensack Meridian Health | 2 |
| MetaCure (USA), Inc. | 2 |
| Morphic Medical Inc. | 2 |
| NYU Langone Health | 2 |
| Sansum Diabetes Research Institute | 2 |
| Stanford University | 2 |
| University Hospital, Strasbourg, France | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 110 |
| Diabetes Mellitus | 24 |
| Obesity | 15 |
| Diabetes Mellitus, Type 1 | 11 |
| Overweight | 5 |
| Hypoglycemia | 4 |
| Insulin Resistance | 4 |
| Hyperglycemia | 3 |
| Hypertension | 3 |
| Prediabetic State | 3 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.